Endothelin B receptor modulates inflammatory pain and cutaneous inflammation

Molecular Pharmacology

Volumn 56, Issue 4, 1999, Pages 807-812

  Griswold, Don E ^a   Douglas, Stephen A ^a   Martin, Lenox D ^a   Davis, T Gregg ^a   Davis, Laura ^a   Ao, Zhaohui ^a   Luttmann, Mark A ^a   Pullen, Mark ^a   Nambi, Ponnal ^a   Hay, Douglas W P ^a   Ohlstein, Eliot H ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 PROPROXYPHENYL) 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIENTHYLPHENYL)AMINOCARBONYLMETHYL]PYRROLIDINE 3 CARBOXYLIC ACID; 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; [[1 BUTYL 5 [ 2 [(2 CARBOXYPHENYL)METHOXY] 4 METHOXY PHENYL] 1H PYRAZOL 4 YL]METHLENE] 6 METHOXY 1,3 BENZODIOXAZOLE 5 PROPANOIC ACID; ARACHIDONIC ACID; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; PHENYLQUINONE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; KNOCKOUT MOUSE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; SKIN INFLAMMATION; TOPICAL DRUG ADMINISTRATION;

ANIMALS; ARACHIDONIC ACID; BENZOQUINONES; BLOTTING, SOUTHERN; DERMATITIS; DIOXOLES; GENOTYPE; HYPERALGESIA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PAIN; POLYMERASE CHAIN REACTION; PYRAZOLES; PYRROLIDINES; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0032851119     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Arai H, Nakao K, Takaya K, Hosada K, Ogawa Y, Nakanishi S and Imura H (1993) The human endothelin-B receptor gene: Structural organization and chromosomal assignment. J Biol Chem 268:3463-3470.
2. Bradley PP, Priebat DA, Christensen RD and Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209.
3. Bull HA, Bunker CB, Terenghi G, Springall DR, Zhao Y, Polak JM and Dowd PM (1991) Endothelin-1 in human skin: immunolocalization, receptor binding, mRNA expression, and effects on cutaneous microvascular endothelial cells. J Invest Dermatol 97:618-623.
4. Carlson RP, O'Neill-Davis L, Chang J and Lewis AJ (1985) Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacological agents. Agents Actions 17:197-204.
5. Douglas SA (1997) Clinical development of endothelin receptor antagonists. Trends Pharmacol Sci 18:408-412.
6. Egger D, Geuenich S, Denzlinger D, Schmitt E, Mailhammer R, Ehernreich H, Dormer P and Huiltmer L (1995) IL-4 renders mast cells functionally responsive to endothelin-1. J Immunol 154:1830-1837.
7. Elferink JGR and de Koster BM (1994) Endothelin-induced activation of neutrophil migration. Biochem. Pharmacol 48:866-871.
8. B receptors. Br J Pharmacol 115:227-236.
9. B receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi. Br J Pharmacol 117:995-999.
10. Griswold DE, Marshall P, Martin L, Webb EF and Zabko-Potapovich B (1991) Analgetic activity of SK&F 105809, a dual inhibitor of arachidonic acid metabolism. Agents Actions 32(Suppl):113-118.
11. Hay DWP, Hubbard WC and Undem BJ (1993a) Endothelin-induced contraction and mediator release in human bronchus. Br J Pharmacol 110:392-398.
12. Hay DWP, Hubbard WC and Undem BJ (1993b) Relative contributions of direct and indirect mechanisms mediating endothelin-induced contraction of guinea-pig trachea. Br J Pharmacol 110:955-962.
13. Hayasaki Y, Nakajima M, Kitano Y, Iwasaki T, Shimamura T and Iwaki K (1996) ICAM-1 expression on cardiac myocytes and aortic endothelial cells via their specificendothelinreceptor subtype. Biochem Biophys Res Commun 229:817-824.
14. Helset E, Ytrehus K, Tveita T, Kjaeve J and Jorgensen L (1994) Endothelin-1 causes accumulation of leukocytes in the pulmonary circulation. Circ Shock 44:201-209.
15. Hosoda K, Nakao K, Tamura N, Arai H, Ogawa Y, Suga S-I, Nakanishi S and Imura H (1992) Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 267:18797-18804.
16. Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A and Yanagisawa M (1994) Targeted and natural (piebald lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79:1267-1276.
17. Lopez-Farre A, Riesco A, Espinosa G, Diguni E, Cernadas MR, Alvarez V, Monton M, Rivas F, Gallego MJ and Egido J (1993) Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation 88:1166-1171.
18. Masaki T, Yanagisawa M and Goto K (1992) Physiology and pharmacology of endothelins. Med Res Rev 12:391-421.
19. McMillen MA and Sumpio BE (1995) Endothelins: Polyfunctional cytokines. J Am Coll Surg 180:621-637.
20. Michael JR and Markewitz BA (1996) Endothelins and the lung. Am J Crit Care Med 154:556-581.
21. Moore DD (1994) Preparation and analysis of DNA, in Current Protocols in Molecular Biology (Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K eds) pp 221-223, John Wiley & Sons, New York.
22. Ohlstein EH, Nambi P, Hay DWP, Gellai M, Brooks DP, Luengo J, Xiang J-N and Elliott JD (1998) Nonpeptide endothelin receptor antagonists. XI. Pharmacological characterization of SB 234551, a potent and highly selective endothelin-A receptor antagonist. J Pharmacol Exp Ther 286:650-656.
23. Piovezan AP, D'Orleans-Juste P, Tonussi CR and Rae GA (1997) Endothelins potentiate formalin-induced nociception and paw edema in mice. Can J Physiol Pharmacol 75:596-600.
24. Puffenberger EG, Hosoda K, Washington SS, Nakao K, deWit D, Yanagisawa M and Chakravarti A (1994) A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 79:1257-1266.
25. B receptors. J Pharmacol Exp Ther 276:647-651.
26. Raffa RB, Schupsky JJ, Lee DKH and Jacoby HI (1996b) Characterization of endothelin-induced nociception in mice: Evidence for a mechanistically distinct analgesic model. J Pharmacol Exp Ther 278:1-7.
27. Rubanyi GM and Polokoff MA (1994) Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 46:325-415.
28. Rubat C, Coudert P, Mavel S, Fialip J and Couquelet J (1997) Effects of two N-arylpiperazinylmethylpyrazolo[1,5-d][1,2,4]triazine derivatives in pain and antidepreesant tests in mice. J Pharm Pharmacol 49:1019-1024.
29. Uchida Y, Ninomiya H, Sakamoto T, Lee JY, Endo T, Nomura A, Hasegawa S and Hirata F (1992) ET-1 released histamine from guinea pig pulmonary but not peritoneal mast cells. Biochem Biophys Res Commun 189:1196-1201.
30. Williams DL Jr, Jones KL, Pettibone DJ, Lis EV and Clineschmidt BV (1991) Sarafotoxin S6c: An agonist which discriminates between endothelin receptor subtypes. Biochem Biophys Res Comm 175:556-561.
31. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K and Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (Lond) 322:411-415.